Boston Scientific lands cardiac patent win over Medtronic

September 18, 2012 by MassDevice staff

A Federal Circuit Court overturns a Medtronic win, sending the case back to a lower court to determine whether Medtronic's cardiac rhythm therapy devices infringe on Boston Scientific's exclusively licensed patents.

legal gavel

Medical device giants Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX) will head back to court to hash out the details of a years-long patent battle over cardiac rhythm therapy device technology.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.